MDMA not approved by the FDA: On Tuesday, an advisory panel from the Food and Drug Administration (FDA) rejected approval for MDMA to be used to treat post-traumatic stress disorder (PTSD). (Technically, this is not a binding decision just yet, but the FDA is expected to follow the advisory panel's ruling and fully reject the drug in August).
"The panel voted 9-2 on whether the MDMA-assisted therapy was effective, and voted 10-1 on whether the proposed treatment's benefits outweighed its risks," reports The New York Times. The result represents a huge setback for MDMA activists, clinicians, patients, and even recreational users who had been anxiously awaiting possible FDA approval and greater acceptance of the drug.
